LYTTON LAURENCE W 13D/13G Filings for Allena Pharmaceuticals, Inc. (ALNAQ)

LYTTON LAURENCE W 13D and 13G filings for Allena Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-05-29
10:17 am
Sale
2020-05-20 13G Allena Pharmaceuticals, Inc.
ALNAQ
LYTTON LAURENCE W 0
0.000%
-37,205,000decrease
(Position Closed)
Filing